149 related articles for article (PubMed ID: 32117706)
1. Endothelial Phosphatase VE-PTP Participates in Vasculogenic Mimicry by Preventing Autophagic Degradation of VE-Cadherin.
Delgado-Bellido D; Bueno-Galera C; López-Jiménez L; Garcia-Diaz A; Oliver FJ
Front Oncol; 2020; 10():18. PubMed ID: 32117706
[TBL] [Abstract][Full Text] [Related]
2. Co-immunoprecipitation of Protein Complexes from Different Subcellular Compartments in Vasculogenic Mimicry Studies.
Delgado-Bellido D; Garcia-Diaz A; Oliver FJ
Methods Mol Biol; 2022; 2514():61-72. PubMed ID: 35771419
[TBL] [Abstract][Full Text] [Related]
3. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry.
Delgado-Bellido D; Zamudio-Martínez E; Fernández-Cortés M; Herrera-Campos AB; Olmedo-Pelayo J; Perez CJ; Expósito J; de Álava E; Amaral AT; Valle FO; Diaz AG; Oliver FJ
Cell Death Dis; 2023 Feb; 14(2):135. PubMed ID: 36797281
[TBL] [Abstract][Full Text] [Related]
4. Vasculogenic Mimicry: Become an Endothelial Cell "But Not So Much".
Fernández-Cortés M; Delgado-Bellido D; Oliver FJ
Front Oncol; 2019; 9():803. PubMed ID: 31508365
[TBL] [Abstract][Full Text] [Related]
5. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.
Delgado-Bellido D; Serrano-Saenz S; Fernández-Cortés M; Oliver FJ
Mol Cancer; 2017 Mar; 16(1):65. PubMed ID: 28320399
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.
Qin Y; Zhao W; Cheng L; Wu S; Wu Q; Gao J; Bian Z; Ma L
Int J Clin Exp Pathol; 2019; 12(7):2462-2473. PubMed ID: 31934073
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.
Zhao N; Sun BC; Sun T; Ma YM; Zhao XL; Liu ZY; Dong XY; Che N; Mo J; Gu Q
Med Oncol; 2012 Dec; 29(5):3599-607. PubMed ID: 22562824
[TBL] [Abstract][Full Text] [Related]
8. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Hess AR; Seftor EA; Gruman LM; Kinch MS; Seftor RE; Hendrix MJ
Cancer Biol Ther; 2006 Feb; 5(2):228-33. PubMed ID: 16481735
[TBL] [Abstract][Full Text] [Related]
9. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
[TBL] [Abstract][Full Text] [Related]
10. Mig-7 expression and vasculogenic mimicry in malignant ovarian tumors.
Czekierdowski A; Czekierdowska S; Stachowicz N; Łoziński T; Gurynowicz G
Ginekol Pol; 2017; 88(10):552-561. PubMed ID: 29192416
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
Liu W; Lv C; Zhang B; Zhou Q; Cao Z
RNA; 2017 Jul; 23(7):1019-1027. PubMed ID: 28396577
[TBL] [Abstract][Full Text] [Related]
13. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Inhibits Vasculogenic Mimicry Via Regulating ETS-1 in Renal Cell Carcinoma.
Chong Y; Xu S; Liu T; Guo P; Wang X; He D; Zhu G
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38299401
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
16. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.
Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D
Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368
[TBL] [Abstract][Full Text] [Related]
17. Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells.
Cong R; Sun Q; Yang L; Gu H; Zeng Y; Wang B
J Exp Clin Cancer Res; 2009 Sep; 28(1):124. PubMed ID: 19735546
[TBL] [Abstract][Full Text] [Related]
18. VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression.
Delgado-Bellido D; Fernández-Cortés M; Rodríguez MI; Serrano-Sáenz S; Carracedo A; Garcia-Diaz A; Oliver FJ
Cell Death Differ; 2019 Jan; 26(2):348-361. PubMed ID: 29786069
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
20. VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism.
Juettner VV; Kruse K; Dan A; Vu VH; Khan Y; Le J; Leckband D; Komarova Y; Malik AB
J Cell Biol; 2019 May; 218(5):1725-1742. PubMed ID: 30948425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
